A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

episode

Neurology Minute not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

2026-09-24- KSR - Hour 1 1h 4m · 24 Sep 2026 · KSR

Daniel Kinahan's podcast with James English due out on same day as next court appearance 9 min · 24 Sep 2026 · Crime World

NPR News: 09-24-2026 11AM EDT 5 min · 24 Sep 2026 · NPR News Now

11AM ET 09/24/2026 Newscast 3 min · 24 Sep 2026 · Fox News Hourly Update

How we get from AI cyberattacks to human extinction 27 min · 24 Sep 2026 · 80,000 Hours Podcast

The Tyler Engle, Bassforge | Matt Beall Podcast 2h 31m · 24 Sep 2026 · Matt Beall Podcast

Report any issue

Source

Recorded31 Jul 2025

Publisherneurologyminute.libsyn.com ↗

Handlerec:10217397

Show notes

Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis. Show reference: https://www.nejm.org/doi/10.1056/NEJMoa2413449

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related